Preferred Label : agonists;
Origin ID : Q000819;
UMLS CUI : C0243192;
Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- False automatic mappings
- Semantic type(s)
https://www.cochrane.org/fr/CD006318/ADDICTN_traitements-dentretien-pour-les-femmes-enceintes-dependantes-aux-opiaces
2020
false
true
false
United Kingdom
France
pregnancy
narcotics
treatment outcome
drug users
review of literature
french abstract
opioid-related disorders
pregnant women
---
https://www.cochrane.org/fr/CD010693/des-medicaments-contre-le-diabete-pour-prevenir-les-accidents-vasculaires-cerebraux-et-autres
false
false
false
France
United Kingdom
meta-analysis
french abstract
stroke
secondary prevention
ischemic attack, transient
peroxisome proliferator-activated receptors
treatment outcome
---
https://www.ema.europa.eu/medicines/human/EPAR/Ozempic
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
semaglutide
semaglutide
drug approval
europe
treatment outcome
adult
diabetes mellitus, type 2
injections, subcutaneous
Pre-filled Pen Syringe
Glucagon-Like Peptide-1 Receptor
Glycated Hemoglobin
cardiovascular diseases
diabetes complications
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
semaglutide
glucagon-like peptides
glucagon-like peptides
---
https://rmlg.uliege.be/article/2974
2018
false
false
false
false
Belgium
French
journal article
diabetes mellitus, type 2
cardiovascular diseases
hypoglycemic agents
empagliflozin
treatment outcome
empagliflozin
Sodium-Glucose transporter 2
comparative effectiveness research
Liraglutide
liraglutide
Glucagon-Like Peptide-1 Receptor
incretins
case reports
prognosis
cardiovascular diseases
drug therapy, combination
diabetes mellitus, type 2
renal insufficiency, chronic
belgium
insurance, health, reimbursement
Clinical Decision-Making
risk factors
Sodium-Glucose Transporter 2 Inhibitors
benzhydryl compounds
glucosides
---
https://www.revmed.ch/RMS/2017/RMS-N-571/Options-therapeutiques-chez-un-patient-diabetique-de-type-2-mal-controle-par-une-insuline-basale
2017
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
administration, oral
insulin
injections, subcutaneous
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
SGLT2 Inhibitor
Sodium-Glucose transporter 2
drug therapy, combination
Glucagon-Like Peptide-1 Receptor
drug combinations
Sodium-Glucose Transporter 2 Inhibitors
---
http://www.amub-ulb.be/revue-medicale-bruxelles/article/les-nouveaux-anti-diabetiques-oraux-1032
2014
false
false
false
false
Belgium
French
journal article
comparative study
diabetes mellitus, type 2
incretins
hypoglycemic agents
administration, oral
incretins
gastric inhibitory polypeptide
glucagon-like peptide 1
dipeptidyl-peptidase iv inhibitors
dipeptidyl peptidase 4 (DPP-4) inhibitors
other blood glucose lowering drugs, excl. insulins
incretins
hypoglycemic agents
hypoglycemic agents
SLC5A2 protein, human
risk factors
drug therapy, combination
treatment outcome
Glucagon-Like Peptide-1 Receptor
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose transporter 2
---
http://www.has-sante.fr/portail/jcms/c_1774157/fr/salvacyl
2014
true
France
French
evaluation of the transparency committee
treatment outcome
Delayed-Action preparations
triptorelin pamoate
insurance, health, reimbursement
gonadotropin-releasing hormone
Paraphilic Disorders
injections, intramuscular
adult
testosterone
triptorelin
---
http://www.revmed.ch/RMS/2014/RMS-N-439/Interet-d-une-combinaison-agoniste-des-recepteurs-du-GLP-1-et-insuline-basale-dans-le-traitement-du-diabete-de-type-2
2014
false
false
false
Switzerland
French
journal article
drug therapy, combination
hypoglycemic agents
diabetes mellitus, type 2
insulin
treatment outcome
Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance)
incretins
drug combinations
blood glucose
gastric emptying
injections, subcutaneous
Delayed-Action preparations
hyperglycemia, postprandial
semaglutide
rGLP-1 protein
body weight
Liraglutide
Glucagon-Like Peptide-1 Receptor
lixisenatide
hyperglycemia
dulaglutide
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
glucagon-like peptides
peptides
venoms
glucagon-like peptide 1
glucagon-like peptide 1
Exenatide
---
http://www.cochrane.org/fr/CD002808
2013
United Kingdom
France
French
french abstract
meta-analysis
gonadotropin-releasing hormone
time
fertilization in vitro
treatment outcome
pituitary gland
---
http://www.cochrane.org/fr/CD008046
2011
false
true
false
France
United Kingdom
chorionic gonadotropin
gonadotropin-releasing hormone
oogenesis
treatment outcome
review of literature
french abstract
gonadotropin-releasing hormone
---
http://www.cochrane.org/fr/CD008235
2011
false
true
false
France
United Kingdom
receptors, thrombopoietin
receptors, thrombopoietin
treatment outcome
review of literature
french abstract
purpura, thrombocytopenic, idiopathic
---
https://medicalforum.ch/fr/detail/doi/fms.2011.07600/
2011
false
true
false
Switzerland
thrombocytopenia
journal article
receptors, thrombopoietin
---
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/13541a-fra.php
2011
Canada
French
English
pharmacovigilance note
Cardiotoxicity
risk
gonadotropin-releasing hormone
gonadotropin-releasing hormone
prostatic neoplasms
stroke
myocardial infarction
---
http://www.has-sante.fr/portail/jcms/c_812373/salvacyl-lp-triptoreline-agoniste-de-la-lhrh
2009
false
France
French
guidelines for drug use
evaluation of the transparency committee
treatment outcome
Delayed-Action preparations
triptorelin pamoate
insurance, health, reimbursement
gonadotropin-releasing hormone
Paraphilic Disorders
injections, intramuscular
adult
testosterone
triptorelin
---
https://www.revmed.ch/RMS/2009/RMS-206/Role-et-place-des-analogues-du-GLP-1-dans-le-traitement-du-diabete-de-type-2
2009
false
Switzerland
French
Liraglutide
Glucagon-Like Peptide-1 Receptor
exenatide
liraglutide
diabetes mellitus, type 2
glucagon-like peptide 1
Product containing glucagon-like peptide 1 receptor agonist (product)
Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance)
hypoglycemic agents
peptides
venoms
journal article
Exenatide
incretins
---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/met/e-docs/00/04/41/01/resume.md?type=text.html
2008
France
French
receptors, thrombopoietin
receptors, thrombopoietin
purpura, thrombocytopenic, idiopathic
journal article
---
